TheEdgeResearch
Home / Stocks / DVA

DaVita Inc. (DVA)

NYSE Healthcare Medical - Care Facilities
$178.12 ▼ -0.13%
Market Cap
$11.43B
Sector
Healthcare
Industry
Medical - Care Facilities
Beta
0.87
52-Wk Range
101-247.49
CEO
Javier J. Rodriguez
Country
US
Currency
USD

DaVita Inc. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Denver, CO, US. The stock last traded at $178.12, down 0.13% on the session, giving a market capitalisation of $11.43B. On trailing twelve-month figures it carries a trailing P/E of 15.32, a net margin of 6.0%. Its beta of 0.87 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
15.32
Price / Sales
0.82
Price / Book
-15.08
EV / EBITDA
7.80
Gross margin
31.0%
Operating margin
15.1%
Net margin
6.0%
Return on equity
Debt / equity
-14.09
Current ratio
1.47
Dividend yield
0.0%
Payout ratio
17.7%
Company profile
Exchange
New York Stock Exchange
Employees
78,000
IPO date
1995-10-31
Headquarters
Denver, CO, US
About DaVita Inc.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Comparable companies

DaVita Inc. is most often compared with the following Healthcare names:

ALGNATRBIOBMRNCHEENSGHSICMOHRVMDUHS
More research on DVA
DVA technical analysis DVA TheEdge Score Compare against peers
Open full interactive analysis & DCF →